无锡药明康德新药开发股份有限公司（药明康德，港交所代码：02359）于2026年3月4日发布截至2026年2月28日的股份变动月报。公告显示，公司本月无新增发行、购回或注销股份活动，整体股本维持不变。
报告期内，药明康德H股已发行股本数量为510,476,909股，A股已发行股本数量为2,473,280,246股，两类股份合计已发行股本总数为2,983,757,155股。根据公告披露，本月未发生任何股份期权、购回与注销、可换股票据或其他导致股本变动的事项。
公司在公告中确认，截至本月底继续符合香港联交所主板上市规则有关公众持股量的规定。该份月报由公司联席公司秘书张月芬签署。总体来看，药明康德在2月期间股本结构保持稳定，未发生股份变动。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.